NPI: 1346760147 · BALTIMORE, MD 21239 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/22/2017
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/22/2017 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,305 | $103K |
| 2019 | 27,433 | $180K |
| 2020 | 24,259 | $337K |
| 2021 | 34,328 | $478K |
| 2022 | 22,044 | $398K |
| 2023 | 11,457 | $366K |
| 2024 | 8,040 | $293K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 37,792 | 3,840 | $1.45M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,689 | 970 | $347K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 50,851 | 2,825 | $244K |
| J1270 | Injection, doxercalciferol, 1 mcg | 25,137 | 2,391 | $62K |
| J1756 | Injection, iron sucrose, 1 mg | 11,390 | 3,057 | $39K |
| 83970 | 3,561 | 3,320 | $5K | |
| A4657 | Syringe, with or without needle, each | 6,772 | 4,008 | $5K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 542 | 239 | $2K |
| 90747 | 32 | 32 | $2K | |
| 83540 | 2,556 | 2,312 | $0.00 | |
| 85041 | 3,907 | 3,593 | $0.00 | |
| 85048 | 3,846 | 3,535 | $0.00 | |
| 0004A | 13 | 12 | $0.00 | |
| 85045 | 34 | 28 | $0.00 | |
| 90662 | 49 | 41 | $0.00 | |
| 82728 | 2,503 | 2,281 | $0.00 | |
| 83550 | 2,410 | 2,182 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,240 | 912 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 136 | 125 | $0.00 |
| 90674 | 97 | 85 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 309 | 297 | $0.00 |